Chronic rhinosinusitis: New understanding of specific and general Quality of life scores

Rhinology. 2016 Dec 1;54(4):289-291. doi: 10.4193/Rhin16.404.


Our goal in treating chronic rhinosinusitis (CRS) is to reduce sinonasal symptoms and improve quality of life (QoL). In patients with CRS, sinonasal symptoms have a significant impact on QoL. Various validated measures exist to quantify QoL such as the 22-item Sinonasal Outcomes Test (SNOT- 22) and MSNOT-20 Young Persons Questionnaire (MSYPQ) specific to CRS, while others measure general QoL, such as the EuroQol 5-Dimensional general health-related QoL survey (EQ5D).

Publication types

  • Editorial
  • Introductory Journal Article

MeSH terms

  • Administration, Topical
  • Adrenal Cortex Hormones / therapeutic use*
  • Biofilms
  • Chronic Disease
  • Endoscopy / adverse effects
  • Endoscopy / methods*
  • Humans
  • Nasal Lavage / methods*
  • Quality of Life*
  • Rhinitis / therapy*
  • Sinusitis / therapy*
  • Skull Base / injuries
  • Surveys and Questionnaires
  • Therapeutic Irrigation / methods
  • Xylitol / therapeutic use*


  • Adrenal Cortex Hormones
  • Xylitol